Related Experiment Videos
[Invasive aspergillosis]
D Caillot1, L Mannone, F Kara-Slimane
1Service d'hématologie clinique Centre hospitalier universitaire Hôpital Le Bocage 21034 Dijon. denis.caillot8@fnac.net
Abstract:
Invasive aspergillosis remains a life-threatening complication in immunocompromised patients. The pulmonary involvement by the aspergillosis is the most common setting. The dissemination of the disease is correlated with the worse prognosis. The overall improvement of the prognosis needs a global diagnostic and therapeutic strategy. In neutropenic patients (mostly at risk of invasive aspergillosis), an early diagnosis can be achieved by systematic use of thoracic CT scan to search halo sign (that seems to be quite specific of the diagnosis in this setting). The early initiation of the antifungal treatment (conventional or liposomal amphotericin or new azole compounds) could be combined with a surgical approach if necessary. This approach could be able to improve the prognosis of aspergillosis. However, the outcome of these patients remains also correlated to the underlying disease.
Insights
Early diagnosis and treatment of invasive aspergillosis in immunocompromised patients, particularly neutropenic individuals, can improve outcomes. Combining thoracic CT scans, antifungal therapy, and surgery offers a strategic approach to managing this severe fungal infection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Invasive aspergillosis is a severe fungal infection, frequently affecting immunocompromised patients.
- Pulmonary involvement is the most common presentation, with dissemination correlating to poorer prognosis.
- Effective management requires integrated diagnostic and therapeutic strategies.
Purpose of the Study:
- To outline a global diagnostic and therapeutic strategy for improving the prognosis of invasive aspergillosis.
- To highlight the role of early diagnosis in neutropenic patients at high risk.
- To emphasize the benefits of prompt antifungal treatment and potential surgical intervention.
Main Methods:
- Systematic use of thoracic CT scans to identify the 'halo sign' for early diagnosis in neutropenic patients.
- Early initiation of antifungal treatment, including conventional amphotericin, liposomal amphotericin, or novel azole compounds.
- Consideration of a surgical approach when necessary, in conjunction with medical management.
Main Results:
- The 'halo sign' on thoracic CT scans appears to be a specific indicator for early diagnosis in at-risk neutropenic patients.
- Early antifungal treatment, combined with surgical intervention if indicated, demonstrates potential for improving aspergillosis outcomes.
- Patient outcomes remain significantly influenced by the severity and nature of the underlying disease.
Conclusions:
- An integrated diagnostic and therapeutic strategy, emphasizing early detection via CT scans and prompt treatment, is crucial for invasive aspergillosis.
- The combination of antifungal therapy and surgical management can enhance patient prognosis.
- Addressing the underlying condition is paramount for successful patient outcomes in invasive aspergillosis.